Boston Scientific Corporation (the "Company") (NYSE:BSX) today announced that American Medical Systems Europe B.V., its wholly owned finance subsidiary, has priced a public offering of €750,000,000 aggregate principal amount of 3.375% notes due 2029 and €1,250,000,000 aggregate principal amount of 3.500% notes due 2032 (collectively, the "Notes"). The Notes will be fully and unconditionally guaranteed by the Company. The offering is being made pursuant to a registration statement filed with the U.S. Securities and Exchange Commission.
Reported Earlier, Boston Scientific Priced Public Offering Of €750M 3.375% Notes Due 2029 And €1.25B 3.500% Notes Due 2032
Company Profile
Fri. 23 Feb 2024, 2:35am ET
Benzinga
News